Published in

ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo), 1(34), 2021

DOI: 10.1590/0102-672020210001e1563

Links

Tools

Export citation

Search in Google Scholar

Brazilian Gastric Cancer Association Guidelines (Part 2): Update on Treatment

Journal article published in 2021 by Leandro Cardoso Barchi ORCID, Marcus Fernando Kodama Pertille Ramos ORCID, André Roncon Dias ORCID, Nora Manoukian Forones ORCID, Marineide Prudêncio de Carvalho ORCID, Osvaldo Antonio Prado Castro ORCID, Paulo Kassab ORCID, Wilson Luiz da Costa-Júnior ORCID, Antônio Carlos Weston ORCID, Bruno Zilberstein ORCID, Álvaro Antônio Bandeira Ferraz, Amir ZeideCharruf, André Brandalise, André Maciel da Silva, Barlon Alves and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown

Abstract

ABSTRACT Background : The II Brazilian Consensus on Gastric Cancer of the Brazilian Gastric Cancer Association BGCA (Part 1) was recently published. On this occasion, countless specialists working in the treatment of this disease expressed their opinion in the face of the statements presented. Aim : To present the BGCA Guidelines (Part 2) regarding indications for surgical treatment, operative techniques, extension of resection and multimodal treatment. Methods: To formulate these guidelines, the authors carried out an extensive and current review regarding each declaration present in the II Consensus, using the Medline/PubMed, Cochrane Library and SciELO databases initially with the following descriptors: gastric cancer, gastrectomy, lymphadenectomy, multimodal treatment. In addition, each statement was classified according to the level of evidence and degree of recommendation. Results : Of the 43 statements present in this study, 11 (25,6%) were classified with level of evidence A, 20 (46,5%) B and 12 (27,9%) C. Regarding the degree of recommendation, 18 (41,9%) statements obtained grade of recommendation 1, 14 (32,6%) 2a, 10 (23,3%) 2b e one (2,3%) 3. Conclusion : The guidelines complement of the guidelines presented here allows surgeons and oncologists who work to combat gastric cancer to offer the best possible treatment, according to the local conditions available.